Aehr Test Systems
AEHR · NASDAQ
5/31/2025 | 5/30/2025 | 5/31/2024 | 5/31/2023 | |
|---|---|---|---|---|
| Revenue | $0 | – | $0 | $0 |
| % Growth | – | – | 1.9% | – |
| Cost of Goods Sold | $0 | – | $0 | $0 |
| Gross Profit | $0 | – | $0 | $0 |
| % Margin | 40.6% | – | 49.1% | 50.4% |
| R&D Expenses | $0 | – | $0 | $0 |
| G&A Expenses | $0 | – | $0 | $0 |
| SG&A Expenses | $0 | – | $0 | $0 |
| Sales & Mktg Exp. | $0 | – | $0 | $0 |
| Other Operating Expenses | $0 | – | $0 | $0 |
| Operating Expenses | $0 | – | $0 | $0 |
| Operating Income | -$0 | – | $0 | $0 |
| % Margin | -7.3% | – | 15.2% | 20.6% |
| Other Income/Exp. Net | $0 | – | $0 | $0 |
| Pre-Tax Income | -$0 | – | $0 | $0 |
| Tax Expense | -$0 | – | -$0 | $0 |
| Net Income | -$0 | – | $0 | $0 |
| % Margin | -6.6% | – | 50.1% | 22.4% |
| EPS | -0.13 | – | 1.151 | 0.524 |
| % Growth | – | – | 119.6% | – |
| EPS Diluted | -0.13 | – | 1.12 | 0.498 |
| Weighted Avg Shares Out | 0 | – | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | – | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | – | $0 | $0 |
| Interest Expense | $0 | – | $0 | $0 |
| Depreciation & Amortization | $0 | – | $0 | $0 |
| EBITDA | -$0 | – | $0 | $0 |
| % Margin | -1.5% | – | 20.9% | 23.2% |